Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Normal Hepatic Function”

242 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 242 results

Early research (Phase 1)Ended earlyNCT02050815
What this trial is testing

MEK162 in Healthy Subjects With Normal Hepatic Function and Subjects With Impaired Hepatic Function

Who this might be right for
Hepatic Impairment
Array Biopharma, now a wholly owned subsidiary of Pfizer 27
Early research (Phase 1)Study completedNCT01631097
What this trial is testing

A Single-Dose Study of Tivozanib in Subjects With Hepatic Impairment and Normal Hepatic Function

Who this might be right for
Hepatic Impairment
AVEO Pharmaceuticals, Inc. 44
Early research (Phase 1)UnknownNCT00935454
What this trial is testing

Hepatocyte Matrix Implant Study

Who this might be right for
Liver DiseaseLiver Cirrhosis
Baermed 10
Early research (Phase 1)Study completedNCT03627754
What this trial is testing

Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics of Glasdegib

Who this might be right for
Hepatic Impairment
Pfizer 24
Early research (Phase 1)Study completedNCT02611505
What this trial is testing

Assess the Effects of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine

Who this might be right for
Hepatic ImpairmentNormal Hepatic Function
Janssen Research & Development, LLC 24
Early research (Phase 1)Study completedNCT02586194
What this trial is testing

Pharmacokinetics Study in Patients With Impaired Hepatic Function

Who this might be right for
Patients With Impaired Hepatic Function
Astellas Pharma Inc 24
Early research (Phase 1)Study completedNCT04016077
What this trial is testing

Evaluate the Pharmacokinetics, Safety and Tolerability of PF-06651600 in Subjects With Hepatic Impairment and Healthy Volunteers

Who this might be right for
Hepatic ImpairmentHealthy Participants
Pfizer 18
Early research (Phase 1)Not Yet RecruitingNCT07055412
What this trial is testing

Y-3 for Injection in Patients With Hepatic Insufficiency and Healthy Subjects

Who this might be right for
Pharmacokinetic DifferencesY-3Saftey+3 more
Neurodawn Pharmaceutical Co., Ltd. 24
Early research (Phase 1)Study completedNCT02871570
What this trial is testing

Evaluate the Effect of IV Doses of Rivipansel in Subjects With Moderate Hepatic Impairment and in Healthy Subjects With Normal Hepatic Function

Who this might be right for
Moderate Hepatic ImpairmentNormal Hepatic Function
GlycoMimetics Incorporated 16
Not applicableUnknownNCT02510963
What this trial is testing

Optimal Time for Tenofovir Treatment of Anti-Hepatitis B Virus (HBV) During the Pregnancy

Who this might be right for
Hepatitis B, Chronic
First Affiliated Hospital Xi'an Jiaotong University 300
Early research (Phase 1)Study completedNCT05882032
What this trial is testing

LY3502970 in Participants With Impaired and Normal Liver Function

Who this might be right for
HealthyHepatic Insufficiency
Eli Lilly and Company 29
Early research (Phase 1)Study completedNCT07248839
What this trial is testing

Assess the Drug Levels and Safety of BMS-986435 in Participants With Normal Hepatic Function and Participants With Different Degrees of Hepatic Impairment

Who this might be right for
Healthy VolunteersHepatic Impairment
Bristol-Myers Squibb 69
Early research (Phase 1)Study completedNCT02891408
What this trial is testing

Study to Evaluate the Pharmacokinetics of Firsocostat or Fenofibrate in Adults With Normal and Impaired Hepatic Function

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Gilead Sciences 74
Early research (Phase 1)Study completedNCT02857868
What this trial is testing

A Trial to Evaluate the Pharmacokinetics of ABL001 in Healthy and Hepatic Impaired Subjects

Who this might be right for
Hepatic Impairment
Novartis Pharmaceuticals 32
Early research (Phase 1)Study completedNCT06916078
What this trial is testing

Lepodisiran (LY3819469) in Participants With Normal, Mild, Moderate, or Severe Liver Function

Who this might be right for
Liver DysfunctionHealthy
Eli Lilly and Company 30
Early research (Phase 1)Study completedNCT03626415
What this trial is testing

A Hepatic Impairment Study for PF-04965842.

Who this might be right for
Hepatic Impairment
Pfizer 24
Early research (Phase 1)Study completedNCT04831944
What this trial is testing

To Evaluate the Safety, and Pharmacokinetics of Parscaclisib in Participants With Normal Hepatic Function and Hepatic Impairment.

Who this might be right for
Advanced Malignancies
Incyte Corporation 21
Early research (Phase 1)Looking for participantsNCT06985615
What this trial is testing

HDM1002 in Subjects With And Without Varying Degrees Of Hepatic Impairement

Who this might be right for
Hepatic ImpairmentHealthy Volunteers
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 40
Early research (Phase 1)WithdrawnNCT05084456
What this trial is testing

Oral Docetaxel in Patients With Normal or Impaired Liver Function

Who this might be right for
Solid Tumor, AdultImpaired Liver Function
Modra Pharmaceuticals
Early research (Phase 1)Study completedNCT00851227
What this trial is testing

Study to Compare Conivaptan in Subjects With Mild & Moderate Liver Impairment Versus Subjects With Normal Liver Function

Who this might be right for
Liver DiseaseHyponatremia
Cumberland Pharmaceuticals 26
Next Page